Drug intelligence / Profile preview

telaprevir + darunavir + ritonavir + fosamprenavir

Development stage
Discontinued
Modality
Small Molecules
Administration
Oral
01

Overview

This is a combination of four antiviral medications that have been studied for potential interactions. Telaprevir is an NS3/4A protease inhibitor used for treating chronic Hepatitis C virus (HCV) genotype 1 infection. Darunavir, ritonavir, and fosamprenavir are HIV protease inhibitors used in antiretroviral therapy for HIV infection. Studies have shown significant drug interactions between these medications, with ritonavir-boosted darunavir and fosamprenavir reducing telaprevir concentrations, and telaprevir reducing darunavir and fosamprenavir levels. Due to these bidirectional interactions, co-administration is not recommended.

02

Targets

NS3/4A (Hepatitis C virus nonstructural protein 3/4A serine protease)PR (Progesterone receptor)

Beyond the preview

Go deeper on telaprevir + darunavir + ritonavir + fosamprenavir.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on telaprevir + darunavir + ritonavir + fosamprenavir.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call